533 — Fort Lauderdale, Florida

533 is a clinical research site located in Fort Lauderdale, Florida, United States.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

533 has participated in 2 clinical trials.

Therapeutic areas: Systemic Lupus Erythematosus.

Sponsors: UCB Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fort Lauderdale

Browse all research sites in Florida · View every site in Fort Lauderdale

• Holy Cross Hospital- Bienes Cancer Center
• Holy Cross Hospital-Michael & Dianne Bienes Comprehensive Cancer Center
• Cathy J Husman ALS Center at Nova Southeastern University
• Broward Health Medical Center & The University of Florida
• Fort Lauderdale Hospital
• Holy Cross Hospital Cancer Center
• Comprehensive Care Center/North Broward Hospital
• Holy Cross Hospital Bienes Comprehensive Cancer Center
• Nova Southeastern University, Health Professions Division, College of Optometry
• Holy Cross Health Fort Lauderdale - Holy Cross Hospital
• Holy Cross Hospital/Orthopedic Institute
• Holy Cross Hospital-Clinical Research ( Site 0159)

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 533?

533 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 533 conducted?

533 has 2 clinical trials on record. Their work covers Systemic Lupus Erythematosus.

Is 533 accredited by Crixeo Clinical Trials?

533 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 533?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.